• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红景天苷在阿尔茨海默病中的神经保护作用机制:临床前研究的系统评价和荟萃分析。

Neuroprotective Mechanisms of Salidroside in Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies.

机构信息

Department of Neurology, Seventh Clinical College of China Medical University, 24 Central Street, Xinfu District, Fushun, Liaoning 113000, People's Republic of China.

Department of Neurology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, Liaoning 110000, People's Republic of China.

出版信息

J Agric Food Chem. 2023 Nov 22;71(46):17597-17614. doi: 10.1021/acs.jafc.3c06672. Epub 2023 Nov 7.

DOI:10.1021/acs.jafc.3c06672
PMID:37934032
Abstract

Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system that occurs in old age and pre-aging, characterized by progressive cognitive dysfunction and behavioral impairment. Salidroside (Sal) is a phenylpropanoid mainly isolated from species with various pharmacological effects. However, the exact anti-AD mechanism of Sal has not been clearly elucidated. This meta-analysis aims to investigate the possible mechanisms by which Sal exerts its anti-AD effects by evaluating behavioral indicators and biochemical characteristics. A total of 20 studies were included, and the results showed that the Sal treatment significantly improved behavior abnormalities in AD animal models. With regard to neurobiochemical indicators, Sal treatment could effectively increase the antioxidant enzyme superoxide dismutase, decrease the oxidative stress indicator malondialdehyde, and decrease the inflammatory indicators interleukin 1β, interleukin 6, and tumor necrosis factor α. Sal treatment was effective in reducing neuropathological indicators, such as amyloid-β levels and the number of apoptotic cells. When the relevant literature on the treatment of rodent AD models is combined with Sal, the therapeutic potential of Sal through multiple mechanisms was confirmed. However, further confirmation by higher quality studies, larger sample sizes, and more comprehensive outcome evaluations in clinical trials is needed in the future.

摘要

阿尔茨海默病(AD)是一种中枢神经系统的神经退行性疾病,发生于老年前期和老年期,其特征为进行性认知功能障碍和行为损害。红景天苷(Sal)是一种苯丙素类化合物,主要从 物种中分离得到,具有多种药理作用。然而,Sal 确切的抗 AD 机制尚未明确。本荟萃分析旨在通过评估行为指标和生化特征,探讨 Sal 发挥抗 AD 作用的可能机制。共纳入 20 项研究,结果表明 Sal 治疗可显著改善 AD 动物模型的行为异常。在神经生化指标方面,Sal 治疗可有效增加抗氧化酶超氧化物歧化酶,降低氧化应激指标丙二醛,降低炎症指标白细胞介素 1β、白细胞介素 6 和肿瘤坏死因子 α。Sal 治疗还可降低神经病理学指标,如淀粉样蛋白-β水平和凋亡细胞数量。当将治疗啮齿动物 AD 模型的相关文献与 Sal 结合时,确认了 Sal 通过多种机制的治疗潜力。然而,未来仍需要更高质量的研究、更大的样本量以及临床试验中更全面的结局评估来进一步证实。

相似文献

1
Neuroprotective Mechanisms of Salidroside in Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies.红景天苷在阿尔茨海默病中的神经保护作用机制:临床前研究的系统评价和荟萃分析。
J Agric Food Chem. 2023 Nov 22;71(46):17597-17614. doi: 10.1021/acs.jafc.3c06672. Epub 2023 Nov 7.
2
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.多奈哌齐、卡巴拉汀、加兰他敏和美金刚用于治疗阿尔茨海默病的临床疗效及成本效益
Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. doi: 10.3310/hta10010.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
5
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.不同吸入性糖皮质激素及其与长效β2受体激动剂联合使用治疗12岁及以上成人和儿童慢性哮喘比较效果的系统评价与经济学分析
Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. doi: 10.3310/hta12190.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
8
Physostigmine for Alzheimer's disease.用于治疗阿尔茨海默病的毒扁豆碱。
Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499.
9
Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies.山奈酚作为阿尔茨海默病治疗剂的作用:来自临床前研究的证据。
Ageing Res Rev. 2023 Jun;87:101910. doi: 10.1016/j.arr.2023.101910. Epub 2023 Mar 15.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Targeting the mTOR Pathway in Hepatocellular Carcinoma: The Therapeutic Potential of Natural Products.靶向肝细胞癌中的mTOR信号通路:天然产物的治疗潜力
J Inflamm Res. 2024 Dec 6;17:10421-10440. doi: 10.2147/JIR.S501270. eCollection 2024.
2
Neuroinflammation of Microglial Regulation in Alzheimer's Disease: Therapeutic Approaches.阿尔茨海默病中小胶质细胞调节的神经炎症:治疗方法。
Molecules. 2024 Mar 26;29(7):1478. doi: 10.3390/molecules29071478.